Medtronic plc (MDT) FY2024 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2023-04-29 to 2024-04-26

Swipe to see the full flow
Medtronic plc cash flow reconciliation, Apr 29, 2023 through Apr 26, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $3,705,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $2,647,000,000.00Other, net → Operating adjustments reconciliation: $573,000,000.00Stock-based compensation → Operating adjustments reconciliation: $393,000,000.00Accounts payable and accrued liabilities → Operating adjustments reconciliation: $391,000,000.00Asset impairments and related inventory write-downs → Operating adjustments reconciliation: $371,000,000.00Provision for credit losses → Operating adjustments reconciliation: $90,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $3,082,000,000.00Operating adjustments reconciliation → Deferred income taxes: $508,000,000.00Operating adjustments reconciliation → Accounts receivable, net: $391,000,000.00Operating adjustments reconciliation → Other operating assets and liabilities: $345,000,000.00Operating adjustments reconciliation → Inventories, net: $139,000,000.00Sales and maturities of investments → investing reconciliation: $7,441,000,000.00investing reconciliation → Purchases of investments: $7,748,000,000.00investing reconciliation → Additions to property, plant, and equipment: $1,587,000,000.00investing reconciliation → Other investing activities, net: $261,000,000.00investing reconciliation → Acquisitions, net of cash acquired: $211,000,000.00Net cash used in financing activities → financing reconciliation: $4,450,000,000.00Change in current debt obligations, net → financing reconciliation: $1,073,000,000.00Issuance of ordinary shares → financing reconciliation: $284,000,000.00financing reconciliation → Dividends to shareholders: $3,666,000,000.00financing reconciliation → Repurchase of ordinary shares: $2,138,000,000.00financing reconciliation → Other financing activities: $3,000,000.00Net cash used in investing activities → investing reconciliation: $2,366,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,543,000,000.00Net cash from operating activities → Cash sources and uses: $6,787,000,000.00Cash sources and uses → Exchange-rate effect: $230,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $1,284,000,000.00Cash sources and uses → Net cash used in investing activities: $2,366,000,000.00Cash sources and uses → Net cash used in financing activities: $4,450,000,000.00Provision for credit losses: $90,000,000.00Credit loss provision+$90.00 MInventories, net: -$139,000,000.00Inventories−$139.00 MNet income: $3,705,000,000.00Net income+$3.71 BOther, net: $573,000,000.00Other non-cash items+$573.00 MOther operating assets and liabilities: -$345,000,000.00Other working capital, net−$345.00 MAccounts receivable, net: -$391,000,000.00Accounts & notes receivable−$391.00 MLoss on debt extinguishment: $0.00Depreciation and amortization: $2,647,000,000.00Depreciation & amortization+$2.65 BDeferred income taxes: -$508,000,000.00Deferred taxes & credits−$508.00 MAsset impairments and related inventory write-downs: $371,000,000.00Asset impairments+$371.00 MStock-based compensation: $393,000,000.00Stock-based compensation+$393.00 MAccounts payable and accrued liabilities: $391,000,000.00Payables & accrued liabilities+$391.00 MNet cash from operating activities: $6,787,000,000.00Operating cash+$6.79 BOperating adjustments reconciliation: $4,465,000,000.00Dividends to shareholders: -$3,666,000,000.00Common dividends paid−$3.67 BIssuance of ordinary shares: $284,000,000.00Equity issued+$284.00 MProceeds from short-term borrowings (maturities greater than 90 days): $0.00Change in current debt obligations, net: $1,073,000,000.00Short-term debt ≤3 months, net+$1.07 BOther financing activities: -$3,000,000.00Other financing, net−$3.00 MRepurchase of ordinary shares: -$2,138,000,000.00Common stock repurchases−$2.14 BPayments on long-term debt: $0.00Issuance of long-term debt: $0.00Repayments from short-term borrowings (maturities greater than 90 days): $0.00Net cash used in financing activities: -$4,450,000,000.00. Cash required to fund net payments.Financing cash−$4.45 Bfinancing reconciliation: $5,807,000,000.00Acquisitions, net of cash acquired: -$211,000,000.00Acquisitions, net of cash−$211.00 MSales and maturities of investments: $7,441,000,000.00Investment sales & maturities+$7.44 BPurchases of investments: -$7,748,000,000.00Investment purchases−$7.75 BAdditions to property, plant, and equipment: -$1,587,000,000.00PP&E purchases−$1.59 BOther investing activities, net: -$261,000,000.00Other investing, net−$261.00 MNet cash used in investing activities: -$2,366,000,000.00. Cash required to fund net payments.Investing cash−$2.37 Binvesting reconciliation: $9,807,000,000.00Cash sources and uses: $8,330,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,543,000,000.00Beginning cash$1.54 BEnding cash: Cash, cash equivalents, and restricted cash: $1,284,000,000.00Ending cash$1.28 BExchange-rate effect: -$230,000,000.00FX effect−$230.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$5.20 BOperating cash − cash spent on PP&ECash flow / Net income1.83×Operating cash flow ÷ net incomeNet cash change−$259.00 MEnding cash − beginning cash
Chart details

Medtronic plc cash flow reconciliation, Apr 29, 2023 through Apr 26, 2024

Cash flows for Apr 29, 2023 through Apr 26, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Apr 28, 2023. Ending cash: Apr 26, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Apr 28, 2023
1,543,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
6,787,000,000 US dollars. Net cash provided.
Provision for credit losses
90,000,000 US dollars
Inventories, net
negative 139,000,000 US dollars
Net income
3,705,000,000 US dollars
Other, net
573,000,000 US dollars
Other operating assets and liabilities
negative 345,000,000 US dollars
Accounts receivable, net
negative 391,000,000 US dollars
Loss on debt extinguishment
0 US dollars
Depreciation and amortization
2,647,000,000 US dollars
Deferred income taxes
negative 508,000,000 US dollars
Asset impairments and related inventory write-downs
371,000,000 US dollars
Stock-based compensation
393,000,000 US dollars
Accounts payable and accrued liabilities
391,000,000 US dollars
Investing activities
negative 2,366,000,000 US dollars. Net cash used.
Acquisitions, net of cash acquired
negative 211,000,000 US dollars
Sales and maturities of investments
7,441,000,000 US dollars
Purchases of investments
negative 7,748,000,000 US dollars
Additions to property, plant, and equipment
negative 1,587,000,000 US dollars
Other investing activities, net
negative 261,000,000 US dollars
Financing activities
negative 4,450,000,000 US dollars. Net cash used.
Dividends to shareholders
negative 3,666,000,000 US dollars
Issuance of ordinary shares
284,000,000 US dollars
Proceeds from short-term borrowings (maturities greater than 90 days)
0 US dollars
Change in current debt obligations, net
1,073,000,000 US dollars
Other financing activities
negative 3,000,000 US dollars
Repurchase of ordinary shares
negative 2,138,000,000 US dollars
Payments on long-term debt
0 US dollars
Issuance of long-term debt
0 US dollars
Repayments from short-term borrowings (maturities greater than 90 days)
0 US dollars
Operating adjustment reconciliation
4,465,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
5,807,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
9,807,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 230,000,000 US dollars
Ending cash on Apr 26, 2024
1,284,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
8,330,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 259,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.83×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
6,787,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
1,587,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
5,200,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $3.08B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 6,787,000,000 US dollars minus 1,587,000,000 US dollars equals 5,200,000,000 US dollars.
Medtronic plc (MDT) FY2024 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!